Newsroom

For press inquiries:

info@cabreracapital.com
(312) 236-8888

Recent News

December 11, 2020
Martin Cabrera named to Crain’s Power 25 List
Crain's Chicago Business
Martin Cabrera named to Crain’s Power 25 List Martin Cabrera, CEO of Cabrera Capital Markets is new to the list and appears as position 21. Read Martin’s Power 25 write-up…
Crain’s Power 25 list, a snapshot of Chicago’s power players in business, labor, politics and health care, takes into account each person’s sphere of influence (what power do they have beyond their title?), direct control (do they make the final call?), access to capital and old-fashioned newsworthiness.
November 19, 2020
Allstate Supports Diversity on Wall Street; Cabrera Co-Manager
Allstate Newsroom
The Allstate Corporation (NYSE: ALL) priced $1.2 billion of 5-year and 10-year senior notes through a syndicate exclusively comprised of minority-, women- and veteran-owned business enterprises (MWVBEs). This is the first time a corporate bond offering of this size has been managed exclusively by MWVBEs.
October 15, 2020
Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares
Global Newswire
Royalty Pharma plc (the “Company”) (Nasdaq: RPRX) announced today the pricing of the secondary offering of 17,343,037 shares of its Class A ordinary shares by selling shareholders in an underwritten public offering pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”) at a price to the public of $42.00 per share.
June 25, 2020
Intentionally Embracing Diversity Enhances Investment Returns
Jagdeep Singh Bachher - CIO, University of California Regents
Six years ago, when the investments team at the University of California began crafting an ESG policy that required environmental, social, and governance risks to be incorporated into all our investment decision making, we laid bare an underlying and ignorant bias within the financial industry.
June 16, 2020
Royalty Pharma Announces Pricing of Initial Public Offering
Globe Newswire
Royalty Pharma Announces Pricing of Initial Public Offering Read Article
- Royalty Pharma plc today announced the pricing of the initial public offering of 77,681,670 shares of its Class A ordinary shares pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (“SEC”) at a price to the public of $28.00 per share.

Videos

Wealth Wednesday with Martin Cabrera of Cabrera Capital Markets

July 26, 2023 | Office of the Chicago City Treasurer

Cabrera Capital CEO Martin Cabrera participated in Wealth Wednesday, a weekly segment hosted by the Office of the Chicago City Treasurer. Martin joined Treasurer Melissa Conyears-Ervin to discuss his career path and how it ultimately led him to the creation of Cabrera Capital. Martin also shared how the firm is making a difference in the community, especially in the field of financial education, through our partnership with Chicago Public Schools.

Diversidad e integración -- Diversity and Latino Inclusion in Business

October 28, 2021 | Mesirow

We discussed the challenges and opportunities facing Latino professionals in finance with Martin Cabrera, Jr., CEO of Cabrera Capital Markets.

Adding value to new bond issues is a relationship business

October 3, 2021 | Primary Markets TV

Adding value to a deal requires his firm to reach out to the 400 investor accounts – including smaller firms by assets under management – and ensuring that the breadth of investors increases pricing and liquidity transparency in the deal. Strengthening relationships with large broker dealer firms and focusing on the capital structure of clients will be core to growth over the next 12 months, Managing Director Santino Bibbo explains.

Menu